Study Comparing Two Different Schedules of Radiation for Early-stage Lung Cancer
NCT03706027 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2025-04-24
Summary
This study's goal is to find out if the kind of side effects people experience from radiation is different depending on the schedule of their radiation treatment. Patients will be randomly assigned to either the 3 Fraction or 5 Fraction schedule of radiation. After patients complete radiation treatment, they will follow up with their radiation oncologist.
Conditions
Interventions
- DEVICE
-
radiation therapy-3 fractions
Radiation therapy given in a 3 fraction schedule (over 3 days). Total dose is 54 Grays.
- DEVICE
-
Radiation therapy-5 fractions
Radiation therapy given in 5 fractions (over 5 days). Total dose is 60 Grays.
Sponsors & Collaborators
-
University of Rochester
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2018-12-15
- Primary Completion
- 2025-11-15
- Completion
- 2026-11-15
- FDA Device
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Hypofractionated Radiation Therapy Combined With Concurrent Chemotherapy for Patients With Non-small Cell Lung Cancer
NCT02720614 ·Status: COMPLETED ·Phase: PHASE2
-
A Feasibility Study Using Four-Dimensional CT Imaging for Primary Lung Cancer
NCT01500876 ·Status: UNKNOWN ·Phase: NA
-
Stereotactic Body Radiation Therapy in Treating Patients With Stage I or Stage II Non-Small Cell Lung Cancer
NCT00471835 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Stereotactic Body Radiation Therapy for Un-biopsied Early- Stage Non Small Cell Lung Cancer
NCT02950337 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Stereotactic Radiation in Patients With Small Cell Lung Cancer and 1-10 Brain Metastases
NCT03391362 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Daily vs. Non-Daily SBRT for NSCLC
NCT03624907 ·Status: TERMINATED ·Phase: NA
-
Single Ultra-high Dose Stereotactic Body Radiation Therapy for Early Lung Cancer
NCT05802654 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Irradiation of Large Lung Tumors or Two or More Lung Metastases Simultaneously
NCT01543672 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Stereotactic Body Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer
NCT00750269 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Hypofractionated vs. Conventionally Fractionated Concurrent CRT for LD-SCLC
NCT02688036 ·Status: UNKNOWN ·Phase: PHASE3
-
Patient-Reported Outcomes Following Chemoradiotherapy for Locally Advanced Non-small Cell Lung Cancer
NCT03481114 ·Status: COMPLETED ·Phase: PHASE2
-
A Pilot Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) in Central Non-Small Cell Lung Cancer
NCT05138900 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Functional Imaging in Lung SBRT
NCT03121300 ·Status: COMPLETED
-
Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer
NCT04210492 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Two Radiation Dose Schedules of SBRT to Lung Metastases < 5cm in Dimension
NCT03029416 ·Status: WITHDRAWN ·Phase: PHASE2
-
Feasibility of Primer Shot Radiotherapy for Non-small Cell Lung Cancer - PRIMER
NCT06528743 ·Status: RECRUITING ·Phase: NA
-
Radiation Therapy in Treating Patients With Stage I Non-Small Cell Lung Cancer And Lung Dysfunction
NCT00009789 ·Status: COMPLETED ·Phase: PHASE1
-
Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35
NCT00958321 ·Status: TERMINATED ·Phase: PHASE2
-
High-Dose 3-Dimensional Conformal Radiation Therapy in Treating Patients With Inoperable Stage I, Stage II, or Stage IIIA Non-Small Cell Lung Cancer
NCT00062335 ·Status: TERMINATED ·Phase: PHASE1
-
3-Dimensional Conformal Radiation Therapy Versus Intensity Modulated Radiation Therapy
NCT00520702 ·Status: COMPLETED ·Phase: PHASE2
-
Radiation Therapy to Relieve Symptoms in Patients With Non-small Cell Lung Cancer
NCT00003685 ·Status: COMPLETED ·Phase: PHASE3
-
Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial
NCT01138722 ·Status: TERMINATED ·Phase: PHASE2
-
Radiation Therapy in Treating Patients With Non-small Cell Lung Cancer
NCT00002577 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Assessing the Efficacy and Safety of Selective Metabolically Adaptive Radiation Dose Escalation in Locally Advanced Non-Small Cell Lung Cancer Receiving Definitive Chemoradiotherapy
NCT02788461 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Combining ICI With SBRT or HypoFrx-RT for ES NSCLC
NCT05451173 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2